Richard Sturm
Atlanta, GANPI 1699738955
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,565 of the $10,706 with a category attached, or 61.3%. AbbVie accounts for 62.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $3,231 and has fallen 85.3% since, to $475 in 2025.
Across 367 payments — averaging $29.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Merz North America, Inc.$1K
- Pfizer$459
- Sanofi$337
- Novartis$301
- Regeneron Healthcare Solutions, Inc.$258
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$4,04038%
- Food & beverage$6,56561%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 223 | $6,650 |
| Merz North America, Inc. | 5 | $1,384 |
| Pfizer | 25 | $459 |
| Sanofi | 15 | $337 |
| Novartis | 31 | $301 |
| Regeneron Healthcare Solutions, Inc. | 12 | $258 |
| Mayne Pharma Commercial LLC | 8 | $213 |
| Johnson & Johnson | 7 | $181 |
| Sun Pharmaceutical Industries Inc. | 8 | $153 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Smith+Nephew | 1 | $103 |
| Lilly USA, LLC | 5 | $90 |
| Galderma Laboratories, L.p. | 5 | $74 |
| Almirall LLC | 4 | $69 |
| LEO Pharma Inc. | 4 | $62 |
| Incyte Corporation | 2 | $44 |
| Amgen | 1 | $28 |
| Sebela Pharmaceuticals Inc. | 1 | $27 |
| Novum Pharma, LLC | 1 | $25 |
| Biofrontera Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Journey Medical Corporation | 1 | $21 |
| Prugen, Inc. Pharmaceuticals | 2 | $16 |
| Aclaris Therapeutics, Inc. | 1 | $15 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $12 |
| Dermavant Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.